Vitrolife AB (VITR)

Stockholm
Currency in SEK
176.70
-2.10(-1.17%)
Closed
VITR Scorecard
Full Analysis
Has raised its dividend for 3 consecutive years
Fair Value
Day's Range
176.10182.80
52 wk Range
156.00268.00
Key Statistics
Edit
Prev. Close
178.8
Open
178.8
Day's Range
176.1-182.8
52 wk Range
156-268
Volume
323.47K
Average Volume (3m)
181.71K
1-Year Change
-8.91%
Book Value / Share
100.74
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VITR Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
269.20
Upside
+52.35%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Vitrolife Company Profile

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.

Employees
1120
Market
Sweden

Vitrolife AB Earnings Call Summary for Q4/2024

  • Q4 sales up 6% to SEK 959M, beating forecast; EPS at 1.03 USD missed expectations of 1.23 USD
  • Full-year sales reached SEK 3,109M, up 4% in local currency; EBITDA margin improved to 34% from 32.3%
  • Stock rose 2.72% post-earnings; company forecasts 5-7% organic growth, focusing on U.S. and China markets
  • CEO emphasized gradual progress; CFO plans to optimize capital structure
  • Challenges include supply chain disruptions, market saturation, and regulatory changes in key markets
Last Updated: 30/01/2025, 10:42
Read Full Transcript

Compare VITR to Peers and Sector

Metrics to compare
VITR
Peers
Sector
Relationship
P/E Ratio
47.3x−1.4x−0.5x
PEG Ratio
0.42−0.020.00
Price/Book
1.8x2.4x2.6x
Price / LTM Sales
6.7x8.0x3.0x
Upside (Analyst Target)
49.0%172.9%56.4%
Fair Value Upside
Unlock20.1%9.9%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 269.20
(+52.35% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.79
Dividend Yield
0.56%
Industry Median 1.08%
Annualised payout
1.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jan 30, 2025
EPS / Forecast
1.03 / 1.23
Revenue / Forecast
959.00M / 945.93M
EPS Revisions
Last 90 days

People Also Watch

72.50
TRUEb
-1.16%
209.4000
BIOAb
-0.76%
305.00
ADDTb
+1.13%
113.90
BILL
+0.18%
388.60
INDUc
-0.31%

FAQ

What Is the Vitrolife (VITR) Stock Price Today?

The Vitrolife stock price today is 176.70

What Stock Exchange Does Vitrolife Trade On?

Vitrolife is listed and trades on the Stockholm stock exchange.

What Is the Stock Symbol for Vitrolife?

The stock symbol for Vitrolife is "VITR."

Does Vitrolife Pay Dividends? What’s The Current Dividend Yield?

The Vitrolife dividend yield is 0.62%.

What Is the Vitrolife Market Cap?

As of today, Vitrolife market cap is 23.95B.

What is Vitrolife Earnings Per Share?

The Vitrolife EPS is 3.79.

What Is the Next Vitrolife Earnings Date?

Vitrolife will release its next earnings report on 23 Apr 2025.

From a Technical Analysis Perspective, Is VITR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.